Pharmdrx Limited
13164381
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
30/06/2025
total exemption full
Next accounts due
31/03/2027
Confirmation statement
Last: 15/02/2026
Due 01/03/2027
Industry
Officers
director · Since 28/01/2021
BUSINESS DEVELOPMENT MANAGER
BRITISH · ENGLAND · Age 38
Also on 1 other board
director · Since 28/01/2021
OPERATIONS MANAGER
BRITISH · ENGLAND · Age 51
Also on 4 other boards
director · Since 28/01/2021
DIRECTOR
CANADIAN · UNITED KINGDOM · Age 50
Also on 8 other boards
Former
director · Resigned 16/06/2021
director · Resigned 28/02/2022
Persons with Significant Control
Mr Graham Thoms
Canadian · United Kingdom · Age 50
43, Nt Accountancy, London, N20 8DG
Notified 02/02/2026
Former PSCs
Mr Graham Thoms
Ceased 28/01/2021
Change History
Active
Private Limited Company
43 NT ACCOUNTANCY
LONDON
CompanyRankvs 27041+ SIC 47910 peers53
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/06/2025
Net Worth
£3k
Balance sheet strength
Cash
£8k
Cash in the bank
Net Current Assets
£2k
Working capital
Current Assets
£12k
Current Liabilities
£9k
Debtors
£3k
Tax at Year End(2024)
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 1.23 | +£0 |
| 2025 | 1.23 | +£0 |
| 2024 | 1.06 | -£8k |
| 2023 | 1.26 | — |
Derived from filed accounts. Not audited figures.